These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 23132731)
1. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers. Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731 [TBL] [Abstract][Full Text] [Related]
2. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer. Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070 [TBL] [Abstract][Full Text] [Related]
3. Zinc-induced modulation of SRSF6 activity alters Bim splicing to promote generation of the most potent apoptotic isoform BimS. Hara H; Takeda T; Yamamoto N; Furuya K; Hirose K; Kamiya T; Adachi T FEBS J; 2013 Jul; 280(14):3313-27. PubMed ID: 23648111 [TBL] [Abstract][Full Text] [Related]
5. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells. Lal S; Allan A; Markovic D; Walker R; Macartney J; Europe-Finner N; Tyson-Capper A; Grammatopoulos DK Sci Signal; 2013 Jul; 6(282):ra53. PubMed ID: 23821771 [TBL] [Abstract][Full Text] [Related]
6. Silencing of voltage-gated potassium channel KV9.3 inhibits proliferation in human colon and lung carcinoma cells. Lee JH; Park JW; Byun JK; Kim HK; Ryu PD; Lee SY; Kim DY Oncotarget; 2015 Apr; 6(10):8132-43. PubMed ID: 25924237 [TBL] [Abstract][Full Text] [Related]
7. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells. Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051 [TBL] [Abstract][Full Text] [Related]
8. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Karni R; de Stanchina E; Lowe SW; Sinha R; Mu D; Krainer AR Nat Struct Mol Biol; 2007 Mar; 14(3):185-93. PubMed ID: 17310252 [TBL] [Abstract][Full Text] [Related]
9. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression. Ezponda T; Pajares MJ; Agorreta J; Echeveste JI; López-Picazo JM; Torre W; Pio R; Montuenga LM Clin Cancer Res; 2010 Aug; 16(16):4113-25. PubMed ID: 20682707 [TBL] [Abstract][Full Text] [Related]
10. RBM4-Nova1-SRSF6 splicing cascade modulates the development of brown adipocytes. Lin JC; Chi YL; Peng HY; Lu YH Biochim Biophys Acta; 2016 Nov; 1859(11):1368-1379. PubMed ID: 27535496 [TBL] [Abstract][Full Text] [Related]
11. The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells. Alvelos MI; Brüggemann M; Sutandy FR; Juan-Mateu J; Colli ML; Busch A; Lopes M; Castela Â; Aartsma-Rus A; König J; Zarnack K; Eizirik DL Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376132 [TBL] [Abstract][Full Text] [Related]
12. The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells. Lin JC; Lee YC; Liang YC; Fann YC; Johnson KR; Lin YJ Sci Rep; 2017 Mar; 7():44204. PubMed ID: 28276498 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC. Das S; Anczuków O; Akerman M; Krainer AR Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246 [TBL] [Abstract][Full Text] [Related]
14. The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes. Filippov V; Filippova M; Duerksen-Hughes PJ Cancer Res; 2007 Aug; 67(16):7621-30. PubMed ID: 17699766 [TBL] [Abstract][Full Text] [Related]
15. DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer. Maglic D; Stovall DB; Cline JM; Fry EA; Mallakin A; Taneja P; Caudell DL; Willingham MC; Sui G; Inoue K J Pathol; 2015 May; 236(1):90-102. PubMed ID: 25537728 [TBL] [Abstract][Full Text] [Related]
16. SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells. Yang X; Zhan P; Feng S; Ji H; Tian W; Wang M; Cheng C; Song B Oncol Rep; 2020 Nov; 44(5):1851-1862. PubMed ID: 32901876 [TBL] [Abstract][Full Text] [Related]
17. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer. de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231 [TBL] [Abstract][Full Text] [Related]
18. Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis. Gabriel M; Delforge Y; Deward A; Habraken Y; Hennuy B; Piette J; Klinck R; Chabot B; Colige A; Lambert C BMC Cancer; 2015 Apr; 15():227. PubMed ID: 25884497 [TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma. Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587 [TBL] [Abstract][Full Text] [Related]
20. RBM25 depletion suppresses the growth of colon cancer cells through regulating alternative splicing of MNK2. Zhi L; Chen C; Zhang G; Huang T; He W; Zhang J; Chen D; Liu J; Zhao J; Qi Y; Wang G; Zhang W; Wang Y Sci China Life Sci; 2024 Oct; 67(10):2186-2197. PubMed ID: 39110401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]